Eugia US LLC 2023-10-11 Health serious FDA
Health · FDA · Recall #FDA-D-0041-2024
Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL… Recall
Issued October 11, 2023 · Eugia US LLC
In October 2023, Eugia US LLC recalled the Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
What you should do
- 1 Stop using Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Eugia US LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Eugia US LLC
- Category
- Health
- Recall date
- October 11, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0041-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Eugia US LLC has 13 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.